Aileron Therapeutics Inc
Biotechnology
Healthcare
ALRN
21.66 M shares
NASDAQ US
traded
10 Jan 2025
listed
no
open
1.96
52 week high
6.93
high
2.17
52 week low
1.65
low
1.96
growth
-46.45 %
previous Close
1.93
P/E ratio
market cap
37.92 M
div yield
0
usd
Sep 2024
qoq
revenue
0.00 %
net incoming
-5.85 M
34.61 %
eps
0.00 %
40.00 %
eps surprise
34.15 %
net profit margin
-584700000.00 %
0.00 %
operating incoming
-6.07 M
32.84 %
net change in cash
-4.27 M
-143.19 %
cash on hand
17.65 M
-19.46 %
cost of revenue
0.00 %
top top